Cargando…

MicroRNAs as the critical regulators of tyrosine kinase inhibitors resistance in lung tumor cells

Lung cancer is the second most common and the leading cause of cancer related deaths globally. Tyrosine Kinase Inhibitors (TKIs) are among the common therapeutic strategies in lung cancer patients, however the treatment process fails in a wide range of patients due to TKIs resistance. Given that the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maharati, Amirhosein, Zanguei, Amir Sadra, Khalili-Tanha, Ghazaleh, Moghbeli, Meysam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905758/ https://www.ncbi.nlm.nih.gov/pubmed/35264191 http://dx.doi.org/10.1186/s12964-022-00840-4

Ejemplares similares

Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells
por: Maharati, Amirhosein, et al.
Publicado: (2023)

MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers
por: Tolue Ghasaban, Faezeh, et al.
Publicado: (2023)

MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cells
por: Tolue Ghasaban, Faezeh, et al.
Publicado: (2023)

Molecular mechanisms of microRNA-216a during tumor progression
por: Hamidi, Amir Abbas, et al.
Publicado: (2023)

MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells
por: Zangouei, Amir Sadra, et al.
Publicado: (2021)

Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells
por: Khalili-Tanha, Ghazaleh, et al.
Publicado: (2021)

Long non-coding RNAs as the critical regulators of PI3K/AKT, TGF-β, and MAPK signaling pathways during breast tumor progression
por: Maharati, Amirhosein, et al.
Publicado: (2023)

MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells
por: Zangouei, Amir Sadra, et al.
Publicado: (2021)

PI3K/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells
por: Maharati, Amirhosein, et al.
Publicado: (2023)

MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer
por: Hamidi, Amir Abbas, et al.
Publicado: (2022)

PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells
por: NAVAEI, ZAHRA NASRPOUR, et al.
Publicado: (2022)

PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression
por: Taghehchian, Negin, et al.
Publicado: (2023)

Long non-coding RNAs as the critical regulators of epithelial mesenchymal transition in colorectal tumor cells: an overview
por: Hamidi, Amir Abbas, et al.
Publicado: (2022)

MicroRNAs as the critical regulators of Forkhead box protein family during gynecological and breast tumor progression and metastasis
por: Taghehchian, Negin, et al.
Publicado: (2023)

Role of the long non-coding RNAs in regulation of Gemcitabine response in tumor cells
por: Maharati, Amirhosein, et al.
Publicado: (2023)

MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells
por: Moghbeli, Meysam
Publicado: (2021)

Role of tyrosine kinases in bladder cancer progression: an overview
por: Zangouei, Amir Sadra, et al.
Publicado: (2020)

Molecular mechanisms of the microRNA-132 during tumor progressions
por: Moghbeli, Meysam, et al.
Publicado: (2021)

Non coding RNAs as the critical factors in chemo resistance of bladder tumor cells
por: Zangouei, Amir Sadra, et al.
Publicado: (2020)

MicroRNA-506 as a tumor suppressor in anaplastic thyroid carcinoma by regulation of WNT and NOTCH signaling pathways
por: Nasrpour Navaei, Zahra, et al.
Publicado: (2023)

Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis
por: Zangouei, Amir Sadra, et al.
Publicado: (2023)

MicroRNAs as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much is missing?
por: Gramantieri, Laura, et al.
Publicado: (2022)

Long non-coding RNAs as the critical factors during tumor progressions among Iranian population: an overview
por: Rahmani, Zahra, et al.
Publicado: (2020)

Genetics of blood malignancies among Iranian population: an overview
por: Ghayour-Mobarhan, Majid, et al.
Publicado: (2020)

MicroRNAs in Synovial Pathology Associated With Osteoarthritis
por: Tavallaee, Ghazaleh, et al.
Publicado: (2020)

Prostate cancer, chronic myelogenous leukemia and multiple myeloma in a single patient: a case report and review of the literature
por: Allahyari, Abolghasem, et al.
Publicado: (2023)

MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung Cancer
por: Fanini, Francesca, et al.
Publicado: (2021)

Methylation as a critical epigenetic process during tumor progressions among Iranian population: an overview
por: Akhlaghipour, Iman, et al.
Publicado: (2021)

Reducing effect of insulin resistance on alpha-synuclein gene expression in skeletal muscle
por: Khoshi, Amirhosein, et al.
Publicado: (2019)

mTORC1-Inhibition Potentiating Metabolic Block by Tyrosine Kinase Inhibitor Ponatinib in Multiple Myeloma
por: Nazim, Uddin Md., et al.
Publicado: (2022)

MicroRNA Expression Profiling of Lung Cancer with Differential Expression of the RON Receptor Tyrosine Kinase
por: Ou, Huilin, et al.
Publicado: (2021)

MicroRNAs: As Critical Regulators of Tumor- Associated Macrophages
por: Chatterjee, Bilash, et al.
Publicado: (2020)

microRNAs: Critical Players during Helminth Infections
por: Rojas-Pirela, Maura, et al.
Publicado: (2022)

Acquired cancer tyrosine kinase inhibitor resistance: ROS as critical determinants
por: Bekeschus, Sander
Publicado: (2021)

MicroRNAs in lung cancer
por: Castro, Diana, et al.
Publicado: (2017)

Therapeutic Potential of Hydrogen-Rich Water on Muscle Atrophy Caused by Immobilization in a Mouse Model
por: Nazari, Seyedeh Elnaz, et al.
Publicado: (2023)

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
por: Pisick, Evan, et al.
Publicado: (2004)

Distinct Response of Circulating microRNAs to the Treatment of Pancreatic Cancer Xenografts with FGFR and ALK Kinase Inhibitors
por: Peran, Ivana, et al.
Publicado: (2022)

Tyrosine Kinase Inhibitors and Interferon
por: Dimou, Maria, et al.
Publicado: (2014)

Tyrosine Kinase Inhibitors for the Elderly
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qvg2doka1or7qn82fcn92pgr1s